Retatrutide 10mg Price in Australia: A$144.99

Current Retatrutide 10mg price in Australia

Pillar Research currently lists Retatrutide 10mg (Reta Peptide) at A$144.99 per vial. The product is in stock in Australia, with same-business-day dispatch for orders placed before the published cut-off. The product page is the canonical source for live price and availability; this article explains what sits behind those figures.

What the listed price includes

• Declared strength: 10mg of lyophilised Retatrutide research material per vial.
• Published purity: 99.493% by HPLC for the released batch.
• Identity check: mass-spectrometry evidence used alongside chromatographic purity.
• Batch record: a downloadable, batch-specific Retatrutide Certificate of Analysis.
• Local fulfilment: stock held and dispatched within Australia rather than sent through an international transshipment route.

What does Retatrutide cost per month?

A monthly figure depends entirely on how many vials a given research protocol uses in that period, and Pillar Research does not provide dosing or protocol guidance for any compound - that decision sits with the researcher and their own study design. What we can give you is the building blocks for your own calculation: the A$144.99 per-vial price, and the volume pricing that applies automatically at checkout - 10% off 2+ vials, 15% at 3+, 20% at 5+, and 30% at 10+. Multiply the per-vial price by however many vials your protocol calls for across the period you're costing, then apply the relevant discount tier.

If your calculation involves reconstitution concentration (mg/mL) rather than just vial count, the peptide reconstitution calculator handles that part of the maths - vial amount and diluent volume in, concentration out, no dosing assumptions built in.

How to compare Retatrutide prices without losing the quality context

Start with the price per stated milligram, but do not stop there. Confirm that the vial strength is explicit, the currency is AUD, the stock status is current, and the COA can be tied to the supplied batch. A generic certificate or an undated purity claim does not establish that the document belongs to the material being offered.

Five checks for a supplier comparison

• Is the offer clearly for Retatrutide 10mg, rather than an ambiguous “Reta” vial?
• Does the displayed amount include GST and clearly identify any shipping charge?
• Is Australian stock genuinely in stock, or is the page collecting pre-orders?
• Does the COA identify the compound, batch, method, result and analysis date?
• Are purity and molecular identity treated as separate analytical questions?

The research peptide COA review checklist and identity-versus-purity guide provide a method-aware way to document those checks.

Price, stock and dispatch can change

Price-intent pages go stale quickly when they copy a figure into multiple places. Pillar Research uses the product record as the source of truth and links this article directly back to it. Before ordering, verify the live A$144.99 price, in-stock label, dispatch countdown and batch COA on the Retatrutide 10mg Australia product page.

Research and compliance context

Retatrutide is supplied by Pillar Research exclusively as Research Use Only material for analytical and in vitro laboratory work. Price and availability language does not imply therapeutic approval or human use. For compound identity and evidence limits, read the single Retatrutide research reference; for the orderable 10mg vial, return to the commercial product page.